Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074
- Conditions
- Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Columbia University Medical Center New York Presbyterian New York, United States
- Seattle Childrens Hospital Seattle, Washington, United States
- Novartis Investigative Site Brisbane, Queensland, Australia